Evaluation of antiarrhythmic and other cardiac activities in some newly synthesized quinazolone compounds.
D031841:Aconitum; D000473:Alkanes; D000818:Animals; D000889:Anti-Arrhythmia Agents / Q000494:pharmacology*; D001145:Arrhythmias, Cardiac / Q000139:chemically induced; D001794:Blood Pressure / Q000187:drug effects; D002302:Cardiac Output / Q000187:drug effects; D003326:Coronary Circulation / Q000187:drug effects; D003331:Coronary Vessels / Q000502:physiology; D004285:Dogs; D004562:Electrocardiography; D004837:Epinephrine; D005260:Female; D006339:Heart Rate / Q000187:drug effects; D007659:Ketones / Q000494:pharmacology / Q000633:toxicity; D007928:Lethal Dose 50; D008026:Ligation; D008297:Male; D011799:Quinazolines / Q000494:pharmacology* / Q000633:toxicity; D013328:Strophanthins; D013329:Structure-Activity Relationship
D000473:Alkanes; D000889:Anti-Arrhythmia Agents; D007659:Ketones; D011799:Quinazolines; D013328:Strophanthins; D004837:Epinephrine